INGREDIENT

Piroctone olamine

Folivis lists piroctone olamine in RESET. Human scalp studies have reported dandruff, scalp-condition and shedding outcomes with other piroctone-olamine formulations, but those results cannot be transferred automatically to Folivis RESET.

Topic: Ingredients, Explained

What it is

Why it is used

RESET currently lists piroctone olamine in its ingredient list.

What the evidence says

What Folivis actually contains — RESET currently lists piroctone olamine in its ingredient list.

What has been studied elsewhere — Published human studies have tested piroctone-olamine-containing shampoos or leave-on formulations for scalp, dandruff and shedding outcomes.

Why formulation still matters — Those studies used different products and concentrations. They do not establish that Folivis RESET produces the same outcome.

EVIDENCE CHAIN

Claims stay connected to their evidence.

EDITORIAL METHOD

Evaluate whether the study tested the exact product, population and outcome relevant to the claim.

Population / context: Readers evaluating product evidence

This is Folivis editorial methodology, not a finding or conclusion attributed to the cited authors.

LABORATORY STUDY

Cinnamic acid research in hair follicle organoids (PMID 38409197)

Folivis uses this source in relation to the following reviewed statement(s):

The cited cinnamic acid study investigated hair follicle organoids in a laboratory setting.

Evaluate whether the study tested the exact product, population and outcome relevant to the claim.

Laboratory findings do not establish Folivis finished-product performance, a consumer dose or a time to results.

This is Folivis editorial methodology, not a finding or conclusion attributed to the cited authors.

Scientific Reports, 2024 ↗

Study record

Cinnamic acid research in hair follicle organoids (PMID 38409197) — Scientific Reports, 2024

Population: Laboratory cell and organoid models, not consumers | Readers evaluating product evidence

Intervention / model: Cinnamic acid evaluated in laboratory hair-related models.

Laboratory findings do not establish Folivis finished-product performance, a consumer dose or a time to results.

This is Folivis editorial methodology, not a finding or conclusion attributed to the cited authors.

IMPORTANT LIMITS

The cited studies used different finished formulations and concentrations. Folivis RESET has not been represented here as a clinically tested antidandruff or hair-loss drug.

This is Folivis editorial methodology, not a finding or conclusion attributed to the cited authors.

RELATED FOLIVIS PRODUCT